Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-05-18 @ 11:51 PM
Study NCT ID:
NCT06034860
Status:
TERMINATED
Last Update Posted:
2024-11-01
First Post:
2023-08-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
Sponsor:
Molecular Templates, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non Small Cell Lung Cancer | View |
| None | Hepatocellular Carcinoma | View |
| None | Melanoma | View |
| None | Renal Cell Carcinoma | View |
| None | Microsatellite Instability High | View |
| None | Mismatch Repair Deficiency | View |
| None | Mesothelioma | View |
| None | Esophageal Squamous Cell Carcinoma | View |
| None | Squamous Cell Carcinoma of Head and Neck | View |
| None | Urothelial Carcinoma | View |
| None | Cervical Cancer | View |
Keywords: